Ligand Pharmaceuticals Inc. (LGND)

97.08
2.14 2.25
NASDAQ : Health Technology
Prev Close 94.94
Open 96.26
Day Low/High 94.65 / 97.84
52 Wk Low/High 88.23 / 278.62
Volume 460.97K
Avg Volume 361.20K
Exchange NASDAQ
Shares Outstanding 19.01M
Market Cap 1.74B
EPS 6.80
P/E Ratio 2.76
Div & Yield N.A. (N.A)

Latest News

6 Stocks with Unusual Volume Activity

6 Stocks with Unusual Volume Activity

When stocks move with unusual volume, it can signal insider buying and selling.

Mylan: 1 of 2 Beaten-Down Biopharmas to Buy

Mylan: 1 of 2 Beaten-Down Biopharmas to Buy

Both it and Ligand Pharmaceuticals look significantly undervalued relative to their prospects.

Ligand upgraded at Deutsche

Ligand downgraded at Deutsche

The Scales Are Tipping Against Weight Watchers International (Plus: KMI, ETP, LGND)

We expect the $30 level to act as resistance.

Ligand downgraded at Deutsche

The Next Big Thing In Biotech: Ligand, BioMarin & Sangamo

The Next Big Thing In Biotech: Ligand, BioMarin & Sangamo

Adam Feuerstein, Sr. Columnist for TheStreet, says Ligand, BioMarin and Sangamo are the next big things to watch in biotech.

Slim Pickings

After a big breakdown and sudden bounce, great charts are hard to find.

Stocks Under $10: Blossoming Biotech Play

Stocks Under $10: Blossoming Biotech Play

Portfolio manager David Peltier discusses a hot biotech stock with a promising clinical pipeline.

A Roundup of Insider Buys

A Roundup of Insider Buys

Here are the industries and stocks that have seen heavy insider buying in the past two weeks.

Ligand Pharma Still Worth a Shot

Ligand Pharma Still Worth a Shot

The damage to a big drug's approval odds is much less than is presently priced into LGND.